Risk of Covid-19 with renin-angiotensin-aldosterone system medications

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2020年 / 1804卷 / 1期
关键词：
D O I：
10.1007/s40278-020-78440-2
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：11 / 11
相关论文
共 50 条
  • [21] Renin-Angiotensin-Aldosterone Inhibitors and COVID-19 Infection
    Tsampasian, Vasiliki
    Corballis, Natasha
    Vassiliou, Vassilios S.
    CURRENT HYPERTENSION REPORTS, 2022, 24 (10) : 425 - 433
  • [22] Renin-angiotensin-aldosterone system peptide profiles in patients with COVID-19
    Kutz, Alexander
    Conen, Anna
    Gregoriano, Claudia
    Haubitz, Sebastian
    Koch, Daniel
    Domenig, Oliver
    Bernasconi, Luca
    Mueller, Beat
    Schuetz, Philipp
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2021, 184 (04) : 543 - 552
  • [23] Risk of severe COVID-19 in hypertensive patients treated with renin-angiotensin-aldosterone system inhibitors
    Golpe, Rafael
    Perez-de-Llano, Luis A.
    Dacal, David
    Guerrero-Sande, Hector
    Pombo-Vide, Beatriz
    Ventura-Valcarcel, Pablo
    MEDICINA CLINICA, 2020, 155 (11): : 488 - 490
  • [24] Safety and Efficacy of Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19 Population
    Sattar, Yasar
    Mukuntharaj, Pradeeksha
    Zghouzi, Mohamed
    Suleiman, Abdul-Rahman M.
    Attique, Hassan
    Ullah, Waqas
    Sana, Muhammad Khawar
    Zaher, Nathan
    Mehmood, Maham
    Doshi, Rajkumar P.
    Panchal, Ankur
    Mir, Tanveer
    Nadeem, Muhammad
    Ali, Omar E.
    Mohamed, Mohamad
    Bagur, Rodrigo
    Elgendy, Islam Y.
    Mamas, Mamas A.
    Alraies, M. Chadi
    HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2021, 28 (04) : 405 - 416
  • [25] COVID-19 pathophysiology may be driven by an imbalance in the renin-angiotensin-aldosterone system
    Susanne Rysz
    Jonathan Al-Saadi
    Anna Sjöström
    Maria Farm
    Francesca Campoccia Jalde
    Michael Plattén
    Helen Eriksson
    Margareta Klein
    Roberto Vargas-Paris
    Sven Nyrén
    Goran Abdula
    Russell Ouellette
    Tobias Granberg
    Malin Jonsson Fagerlund
    Johan Lundberg
    Nature Communications, 12
  • [26] The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19
    Mascolo, Annamaria
    Scavone, Cristina
    Rafaniello, Concetta
    De Angelis, Antonella
    Urbanek, Konrad
    di Mauro, Gabriella
    Cappetta, Donato
    Berrino, Liberato
    Rossi, Francesco
    Capuano, Annalisa
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [27] COVID-19 pathophysiology may be driven by an imbalance in the renin-angiotensin-aldosterone system
    Rysz, Susanne
    Al-Saadi, Jonathan
    Sjostrom, Anna
    Farm, Maria
    Jalde, Francesca Campoccia
    Platten, Michael
    Eriksson, Helen
    Klein, Margareta
    Vargas-Paris, Roberto
    Nyren, Sven
    Abdula, Goran
    Ouellette, Russell
    Granberg, Tobias
    Fagerlund, Malin Jonsson
    Lundberg, Johan
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [28] Renin-Angiotensin-Aldosterone Inhibitors and Susceptibility to and Severity of COVID-19
    Curfman, Gregory
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (02): : 177 - 178
  • [29] Effect of renin-angiotensin-aldosterone system inhibitors on Covid-19 patients in Korea
    Park, Jungchan
    Lee, Seung-Hwa
    You, Seng Chan
    Kim, Jinseob
    Yang, Kwangmo
    PLOS ONE, 2021, 16 (03):
  • [30] The renin angiotensin aldosterone system and COVID-19
    Alsufyani, Hadeel A.
    Docherty, James R.
    SAUDI PHARMACEUTICAL JOURNAL, 2020, 28 (08) : 977 - 984
12345